Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M K Haseman

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|July 13, 2002
The role of (111)In Capromab Pendetide (Prosta-ScintR) immunoscintigraphy in the management of prostate cancerL M Freeman, B R Krynyckyi, Y Li, et al.
Journal of Surgical Oncology|December 1, 1992
Gamma probe location of 111indium-labeled B72.3: an extension of immunoscintigraphyD N Krag, M K Haseman, P Ford, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1985
Chelate conjugates of monoclonal antibodies for imaging lymphoid structures in the mouseD A Goodwin, C F Meares, M J McCall, et al.
The Journal of Urology|May 23, 1998
111Indium-capromab pendetide in the evaluation of patients with residual or recurrent prostate cancer after radical prostatectomy. The ProstaScint Study GroupD Kahn, R D Williams, M J Manyak, et al.
European Journal of Nuclear Medicine|January 1, 1986
Metabolizable 111In chelate conjugated anti-idiotype monoclonal antibody for radioimmunodetection of lymphoma in miceM K Haseman, D A Goodwin, C F Meares, et al.
Cancer|April 8, 1999
Comparison of clinical staging algorithms and 111indium-capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patientsT J Polascik, M J Manyak, M K Haseman, et al.
The Annals of Thoracic Surgery|December 1, 1995
Staging non-small cell lung cancer by whole-body positron emission tomographic imagingP E Valk, T R Pounds, D M Hopkins, et al.
Archives of Surgery (Chicago, Ill. : 1960)|May 14, 1999
Whole-body PET imaging with [18F]fluorodeoxyglucose in management of recurrent colorectal cancerP E Valk, E Abella-Columna, M K Haseman, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|July 13, 2002
The role of (111)In Capromab Pendetide (Prosta-ScintR) immunoscintigraphy in the management of prostate cancerL M Freeman, B R Krynyckyi, Y Li, et al.
Journal of Surgical Oncology|December 1, 1992
Gamma probe location of 111indium-labeled B72.3: an extension of immunoscintigraphyD N Krag, M K Haseman, P Ford, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1985
Chelate conjugates of monoclonal antibodies for imaging lymphoid structures in the mouseD A Goodwin, C F Meares, M J McCall, et al.
The Journal of Urology|May 23, 1998
111Indium-capromab pendetide in the evaluation of patients with residual or recurrent prostate cancer after radical prostatectomy. The ProstaScint Study GroupD Kahn, R D Williams, M J Manyak, et al.
European Journal of Nuclear Medicine|January 1, 1986
Metabolizable 111In chelate conjugated anti-idiotype monoclonal antibody for radioimmunodetection of lymphoma in miceM K Haseman, D A Goodwin, C F Meares, et al.
Cancer|April 8, 1999
Comparison of clinical staging algorithms and 111indium-capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patientsT J Polascik, M J Manyak, M K Haseman, et al.
The Annals of Thoracic Surgery|December 1, 1995
Staging non-small cell lung cancer by whole-body positron emission tomographic imagingP E Valk, T R Pounds, D M Hopkins, et al.
Archives of Surgery (Chicago, Ill. : 1960)|May 14, 1999
Whole-body PET imaging with [18F]fluorodeoxyglucose in management of recurrent colorectal cancerP E Valk, E Abella-Columna, M K Haseman, et al.
Pageof 2